Stefan Zajic, PhD

Principal Research Scientist, Coriell Personalized Medicine Collaborative

Stefan Zajic, PhD, is a principal research scientist at the Coriell Institute and currently serves as the scientific lead for the Camden Opioid Research Initiative, a collaborative investigation into the genetic and non-genetic risk factors for opioid use disorder, also called opioid dependence or addiction.

Prior to CORI, Stefan focused on the Coriell Personalized Medicine Collaborative (CPMC), a research study examining the clinical utility of genetic information. In this role, Stefan interfaced with the study team to execute a number of chief initiatives – experimental design, data collection and analysis, and the pursuit of research funding.

Before coming to Coriell, Stefan was a principal scientist in research and development with Merck & Co., contributing to quantitative pharmacology and pharmacometrics analyses and using mathematical modeling and simulation to address key clinical questions.

Stefan received his undergraduate degree from the University of Pennsylvania and earned his doctorate in chemical engineering from the Massachusetts Institute of Technology.